Insiders Genmab A/S

Equities

GMAB

DK0010272202

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:56 2024-04-26 am EDT			5-day change	1st Jan Change
1,954 ^DKK	+2.04%		-2.57%	-9.30%

Apr. 16	Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug	MT
Apr. 16	Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Genmab A/S Announces Executive Changes	Mar. 13	CI
Danish Biotechnology Group Genmab Names New Chief Strategy Officer	23-03-28	MT
Genmab A/S Announces Appointment of Martine van Vugt to Chief Strategy Officer and Promotes to Executive Vice President Effective March 29, 2023	23-03-28	CI
Avantor Names Jonathan Peacock Chairman	22-05-13	MT
Genmab A/S Elects Elizabeth O’Farrell to the Board of Directors	22-03-29	CI
Genmab Announces the Nomination of a New Member of the Company's Board of Directors	22-03-15	AQ
Genmab A/S : Announces the Nomination of a New Member of the Company’s Board of Directors - Form 6-K	22-03-14	PU
Genmab Announces the Nomination of a New Member of the Company’s Board of Directors	22-03-14	GL
Genmab Appoints New Chief Legal Officer, Chief People Officer	22-03-01	MT
Genmab A/S Announces Appointments of Birgitte Stephensen to Chief Legal Officer and Chris Cozic to Chief People Officer	22-03-01	CI
Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines	21-02-22	CI
Genmab A/S Appoints Pernille Erenbjerg as Deputy Chairman	20-03-26	CI
Genmab A/S Announces the Election of Mr. Jonathan Peacock to its Board of Directors for a One-Year Period	20-03-26	CI
Genmab A/S Announces Anthony Mancini Will Join the Company as Executive Vice President and Chief Operating Officer, Effective March 23, 2020	20-03-10	CI
Genmab' Chairman of the Board of Directors, Mats Pettersson to Step Down from the Board At Annual General Meeting on March 26, 2020	20-02-21	CI
Genmab A/S Announces Executive Changes	19-10-30	CI
Genmab A/S Announces Management Changes	19-03-11	CI
Genmab A/S Appoints Judith Klimovsky as Executive Vice President and Chief Development Officer, Effective February 13, 2017	17-02-08	CI
Genmab A/S Nominates Rolf Hoffmann to its Board of Directors	16-08-03	CI
Genmab A/S Announces Board Appointments	15-03-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GENMAB : Genmab is available at a bargain price

March 04, 2024 at 06:10 am EST